Marking a fundamental shift in how we define acceptable clinical proof, it has indicated that one well-controlled trial, ...
Dhillon outlined that over the next 90 days and into 2026, the company will "generate a more complete picture of nimasimab's potential using insights from our PK and PD modeling and the ongoing ...
Modella AI has signed a multi-year agreement with AstraZeneca to expedite AI-driven oncology clinical development. The partnership will give AstraZeneca access to Modella AI’s multi-modal foundation ...
New York, New York-- (Newsfile Corp. - April 15, 2026) - Leading B2B platform DesignRush has released its April 2026 ranking of the top AI development agencies. DesignRush recognizes top AI ...
As cities around the world continue to expand and evolve, understanding the dynamics of the housing market becomes increasingly critical for urban planners, ...
Last year marked an inflection point for data centers. Artificial intelligence-driven development made the sector a primary engine of U.S. economic growth, turned the industry into a political issue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results